OSHEA WILLIAM J
Insider CIK 1251725 · ZLCS Director · OCUL Director · MAPP Director · TRVI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 478,951 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 307,607 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 99,046 | — | $0 | 114,080 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | A Award deriv | 2018-06-14 | 2018-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | A Award deriv | 2017-06-01 | 2017-06-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | A Award deriv | 2016-06-02 | 2016-06-03 | 13,500 | — | $0 | 13,500 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | A Award deriv | 2015-11-05 | 2015-11-09 | 11,363 | — | $0 | 11,363 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| ZLCS Zalicus Inc. | A Award deriv | 2012-05-23 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | A Award deriv | 2012-01-13 | 2012-01-17 | 20,000 | — | $0 | 20,000 | SEC↗ |